Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma.
about
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyThe effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects.Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trialFluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthmaA2B adenosine receptor expression by myeloid cells is proinflammatory in murine allergic-airway inflammationIntegrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.Asthma: beyond corticosteroid treatment.Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.Issues determining direct airways hyperresponsiveness in mice.The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.
P2860
Q28074802-00155F26-1429-4304-8DFE-E29B906A7458Q34644860-D52602E4-C0D5-47AF-A36D-8181ABEC2F4DQ35554841-250B43E8-513F-402E-998D-AF3ADA014B8CQ35766467-E385B523-E4C9-45AE-9699-E24486BB9A77Q36252460-D3C3AD8B-D140-4C1C-9351-20CA9C88ABB7Q37436410-E1A63364-8C86-4E79-8420-4B314F76AC85Q38121086-B3A13D16-31AD-4A8D-9FBE-98A4D1C4B088Q38707759-B3461EDE-1785-4E07-9139-E43B5E436465Q38851423-8948B9B4-8857-487A-B791-3FC0B6358A4AQ38947467-D6A49751-58A7-462C-B38D-DBBB543C462CQ42253470-2EBFF9C0-1969-459A-A1C2-49E33F53DB43Q51671642-FD8AC95E-1455-4000-867D-E2513792A38D
P2860
Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Prolonged protection of the ne ...... eness in patients with asthma.
@en
Prolonged protection of the ne ...... eness in patients with asthma.
@nl
type
label
Prolonged protection of the ne ...... eness in patients with asthma.
@en
Prolonged protection of the ne ...... eness in patients with asthma.
@nl
prefLabel
Prolonged protection of the ne ...... eness in patients with asthma.
@en
Prolonged protection of the ne ...... eness in patients with asthma.
@nl
P2093
P1433
P1476
Prolonged protection of the ne ...... eness in patients with asthma.
@en
P2093
D S Postma
J-W J Lammers
M van den Berge
P Bareille
P2860
P304
P356
10.1111/J.1398-9995.2010.02414.X
P577
2010-12-01T00:00:00Z